Literature DB >> 26561677

Update in Pulmonary Vascular Diseases 2014.

Elena A Goncharova, Mark T Gladwin, Steven M Kawut.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26561677      PMCID： PMC4595695          DOI： 10.1164/rccm.201504-0829up

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  52 in total

1.  Sex-dependent influence of endogenous estrogen in pulmonary hypertension.

Authors:  Kirsty M Mair; Audrey F Wright; Nicholas Duggan; David J Rowlands; Martin J Hussey; Sonia Roberts; Josephine Fullerton; Margaret Nilsen; Lynn Loughlin; Matthew Thomas; Margaret R MacLean
Journal:  Am J Respir Crit Care Med       Date:  2014-08-15       Impact factor: 21.405

Review 2.  The genetics of pulmonary arterial hypertension.

Authors:  Eric D Austin; James E Loyd
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

3.  Pulmonary hypertension due to fibrotic lung disease: hidden value in a neutral trial.

Authors:  Steven D Nathan; Roberto G Carbone
Journal:  Am J Respir Crit Care Med       Date:  2014-07-15       Impact factor: 21.405

Review 4.  Novel and emerging therapies for pulmonary hypertension.

Authors:  Soni Savai Pullamsetti; Ralph Schermuly; Ardeschir Ghofrani; Norbert Weissmann; Friedrich Grimminger; Werner Seeger
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

5.  Effects of red-cell storage duration on patients undergoing cardiac surgery.

Authors:  Marie E Steiner; Paul M Ness; Susan F Assmann; Darrell J Triulzi; Steven R Sloan; Meghan Delaney; Suzanne Granger; Elliott Bennett-Guerrero; Morris A Blajchman; Vincent Scavo; Jeffrey L Carson; Jerrold H Levy; Glenn Whitman; Pamela D'Andrea; Shelley Pulkrabek; Thomas L Ortel; Larissa Bornikova; Thomas Raife; Kathleen E Puca; Richard M Kaufman; Gregory A Nuttall; Pampee P Young; Samuel Youssef; Richard Engelman; Philip E Greilich; Ronald Miles; Cassandra D Josephson; Arthur Bracey; Rhonda Cooke; Jeffrey McCullough; Robert Hunsaker; Lynne Uhl; Janice G McFarland; Yara Park; Melissa M Cushing; Charles T Klodell; Ravindra Karanam; Pamela R Roberts; Cornelius Dyke; Eldad A Hod; Christopher P Stowell
Journal:  N Engl J Med       Date:  2015-04-09       Impact factor: 91.245

6.  Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry.

Authors:  M J del Cerro Marín; A Sabaté Rotés; A Rodriguez Ogando; A Mendoza Soto; M Quero Jiménez; J L Gavilán Camacho; I Raposo Sonnenfeld; A Moya Bonora; D C Albert Brotons; A Moreno Galdó
Journal:  Am J Respir Crit Care Med       Date:  2014-12-15       Impact factor: 21.405

7.  Echocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosis.

Authors:  Belinda N Rivera-Lebron; Paul R Forfia; Maryl Kreider; James C Lee; John H Holmes; Steven M Kawut
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

8.  Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension.

Authors:  Julia Hoffmann; Jochen Wilhelm; Leigh M Marsh; Bahil Ghanim; Walter Klepetko; Gabor Kovacs; Horst Olschewski; Andrea Olschewski; Grazyna Kwapiszewska
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

Review 9.  Cellular and molecular basis of pulmonary arterial hypertension.

Authors:  Nicholas W Morrell; Serge Adnot; Stephen L Archer; Jocelyn Dupuis; Peter Lloyd Jones; Margaret R MacLean; Ivan F McMurtry; Kurt R Stenmark; Patricia A Thistlethwaite; Norbert Weissmann; Jason X-J Yuan; E Kenneth Weir
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

10.  Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.

Authors:  Dmitry A Goncharov; Tatiana V Kudryashova; Houman Ziai; Kaori Ihida-Stansbury; Horace DeLisser; Vera P Krymskaya; Rubin M Tuder; Steven M Kawut; Elena A Goncharova
Journal:  Circulation       Date:  2013-11-22       Impact factor: 29.690
View more
  3 in total

1.  Translational Advances in the Field of Pulmonary Hypertension Bench to Bedside: How Fundamental Discoveries in Science Are Advancing Our Understanding and Therapy of Pulmonary Arterial Hypertension.

Authors:  Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

2.  Recommendations on RBC Transfusion in Infants and Children With Acquired and Congenital Heart Disease From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Jill M Cholette; Ariane Willems; Stacey L Valentine; Scot T Bateman; Steven M Schwartz
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

3.  Frequent mutation of hypoxia-related genes in persistent pulmonary hypertension of the newborn.

Authors:  Mingbang Wang; Deyi Zhuang; Mei Mei; Haiyan Ma; Zixiu Li; Fusheng He; Guoqiang Cheng; Guang Lin; Wenhao Zhou
Journal:  Respir Res       Date:  2020-02-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.